Sandexis is a partnership of highly experienced medicinal and computational chemists working at the cutting edge of modern medicinal chemistry. We have more than 60 years of collective experience at Pfizer and Merck, encompassing 15 clinical candidates across multiple disease areas. Sandexis provide support in the following areas to biotechnology and pharmaceutical companies, and not-for-profit research organisations: • Medicinal chemistry drug design • Molecular modelling • Management of integrated drug discovery projects • Management of outsourced synthetic chemistry • Neglected disease initiatives • Due diligence and technical reviews • Grant proposal content and advice Please contact us for further information about these services or to discuss any specific requirements that we can help you with. info@sandexis.co.uk http://www.sandexis.co.uk
Looking for a particular Sandexis employee's phone or email?
The Sandexis annual revenue was $74.1 million in 2026.
James Mills is the Co-founder and Partner of Sandexis.
3 people are employed at Sandexis.
The NAICS codes for Sandexis are [54171, 5417, 541713, 54, 541].
The SIC codes for Sandexis are [87, 873].